Navigation Links
PRA Named "Clinical Company of the Year" in National Contest for Second Year
Date:11/20/2013

RALEIGH, N.C., Nov. 20, 2013 /PRNewswire/ -- PRA, a leading clinical research organization, today announced it has won the 2013 U.S. Clinical Researcher of the Year's "Clinical Company of the Year" award for the second consecutive year, as well as several individual honors at the competition's finals ceremony held recently in Cary, NC. Included in PRA's individual winners was a clean sweep of the Project Management category, where PRA claimed first, second, and third place.

Organized by PharmaTimes, the event named PRA "Clinical Company of the Year" based on the total points earned by its employees' performances in individual competitions. Fourteen PRA employees across four categories were invited to attend the in-person finals competition. They competed with nearly 200 other contestants in a rigorous three-phase process that tested their skills in risk-based monitoring and virtual teamwork.

"This contest allows our employees to compete against other talented professionals in the clinical research industry," said PRA Executive Vice President of Product Registration-Americas, Andrew Strayer. "Being named 'Clinical Company of the Year' for the second year in a row is an achievement that speaks to the level of commitment and dedication of our employees."

PRA employees earning this year's awards include: Lee Steen, second place, New Clinical Research Associate category; Promise Lawrence, first place, Project Manager category; Sarah Connell, second place, Project Manager category; and Adrienne Stoudenmire, third place, Project Manager category.

About PRA

One of the world's largest CROs, PRA is transforming clinical trials through our people, innovation and operational transparency. Our 10,000+ employees operate in more than 80 countries, delivering a broad spectrum of full-service and Embedded clinical trial solutions that meet the demands of a diverse marketplace.

PRA's Early Development Services group is committed to the highest standards of clinical excellence and scientific expertise. We operate state-of-the-art facilities in The Netherlands and North America as well as an innovative patient pharmacology model in Central and Eastern Europe providing the pharmaceutical and biotech industries with the unique scientific environment required for complex compound development and testing. In addition, PRA's harmonized laboratory facilities in The Netherlands and the US are situated close to the clinical facilities and are configured to fully support all clinical study requirements.

Over the last 30+ years, PRA has established a reputation for specialized expertise and success in a variety of compounds, ranging from niche treatments and therapies to blockbuster drugs. Our forward-thinking approach to clinical research innovation, customized recruitment strategies and technological advances continues to make a difference to healthcare patients around the world.

To learn more about PRA, please visit praintl.com, email clearlypra@praintl.com.


'/>"/>
SOURCE PRA
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Vasomedical Again Named on Deloittes Technology Fast 500 List
2. Edith Sanford Breast Cancer Foundation Named Official Charity Partner of Womens Running Series
3. ISPE Named as a Source in FDA Strategic Plan for Preventing and Mitigating Drug Shortages
4. PRA Staff Named Finalists in Clinical Researcher of the Year Competition
5. AbbVie Named a Science Top Employer
6. BioTrackTHC Named Washington States Legal Marijuana Traceability System
7. United Spinal Named Beneficiary Of Permobils 3rd Annual Charity Golf Tournament
8. XYMOGEN Named Among The Nations Fastest Growing Private Companies For The Sixth Time
9. PTS, Inc. Named to Inc. 500/5000 Fastest Growing Private Companies for Third Time
10. Philadelphia Business Journal has named Hope Paige Medical ID one of its Best Places to Work in Philadelphia
11. USANA Named One Of Americas Best Places To Work By Outside Magazine For 5th Consecutive Year
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... 2016 Capricor Therapeutics, Inc. ... biotechnology company focused on the discovery, development and ... enrollment in its ongoing randomized HOPE-Duchenne clinical trial ... of its 24-patient target. Capricor expects the trial ... of 2016, and to report top line data ...
(Date:6/23/2016)... Pa. , June 23, 2016 Bracket ... will launch its next generation clinical outcomes platform, Bracket eCOA ... Meeting held on June 26 – 30, 2016 in ... the first electronic Clinical Outcome Assessment product of its kind ... Booth #715. Bracket eCOA 6.0 is a flexible ...
(Date:6/23/2016)... INDIANAPOLIS , June 23, 2016 ... Tomorrow,s Leaders Scholarship is any indication, the future is ... online at www.diabetesscholars.org by the Diabetes Scholars ... in the way of academic and community service excellence. ... program since 2012, and continues to advocate for people ...
Breaking Medicine Technology:
(Date:6/26/2016)... ... June 26, 2016 , ... Pixel Film Studios Released ProSlice Levels, ... editors can give their videos a whole new perspective by using the title ... Pixel Film Studios. , ProSlice Levels contains over 30 Different presets to choose ...
(Date:6/26/2016)... Lake Orion, Clarkston, Michigan (PRWEB) , ... June ... ... direction with respect to fertility once they have been diagnosed with endometriosis. These ... tolerable intercourse but they also require a comprehensive approach that can help for ...
(Date:6/25/2016)... ... June 25, 2016 , ... The temporary closing of Bruton Memorial Library on June ... , brings up a new, often overlooked aspect of head lice: the parasite’s ability to ... is not a common occurrence, but a necessary one in the event that lice have ...
(Date:6/25/2016)... ... , ... As a lifelong Southern Californian, Dr. Omkar Marathe earned his Bachelors ... Geffen School of Medicine at UCLA. He trained in Internal Medicine at Scripps Green ... hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he had the opportunity to train ...
(Date:6/25/2016)... ... ... Conventional wisdom preaches the benefits of moderation, whether it’s a matter of ... too high can result in disappointment, perhaps even self-loathing. However, those who set the ... Research from PsychTests.com reveals that behind the tendency to set low expectations ...
Breaking Medicine News(10 mins):